LATE CELL CYCLE SIGNATURES STRATIFY GEMDOCE RESPONSES FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Gabrielson, Andrew
Epstein, Gabriel
Feng, Mingxiao
Patel, Sunil
Kates, Max
Choi, Woonyoung
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-16
引用
收藏
页码：E188 / E189
页数：2
相关论文
共 50 条
  • [1] Current advances in BCG-unresponsive non-muscle invasive bladder cancer
    Tse, Jennifer
    Singla, Nirmish
    Ghandour, Rashed
    Lotan, Yair
    Margulis, Vitaly
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (09) : 757 - 770
  • [2] Therapeutic Advances in Bladder Preservation for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
    Lange, Alyssa
    Madiraju, Srigita
    Petros, Firas G.
    CANCERS, 2025, 17 (04)
  • [3] BCG-unresponsive non-muscle invasive bladder cancer: recommendations from the IBCG
    Kamat, Ashish M.
    Colombel, Marc
    Sundi, Debasish
    Lamm, Donald
    Boehle, Andreas
    Brausi, Maurizio
    Buckley, Roger
    Persad, Raj
    Palou, Joan
    Soloway, Mark
    Witjes, J. Alfred
    NATURE REVIEWS UROLOGY, 2017, 14 (04) : 244 - 255
  • [4] HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    de Jong, Joep
    Hendricksen, Kees
    Rosier, Marloes
    Boormans, Joost
    Mostafid, Hugh
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1234 - E1235
  • [5] Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancer
    Dutto, Daniele
    Livoti, Simone
    Soria, Francesco
    Gontero, Paolo
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (10) : 1335 - 1348
  • [6] PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Shore, Neal
    O'Donnell, Michael
    Keane, Thomas
    Jewett, Michael A. S.
    Kulkarni, Girish S.
    Dickstein, Rian
    Wolk, Fred
    Dunshee, Curtis
    Belkoff, Laurence
    Dillon, Rachelle L.
    Cizeau, Jeannick
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2020, 203 : E72 - E72
  • [7] PATIENT PREFERENCES FOR TREATMENT OF BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: A DISCRETE CHOICE EXPERIMENT
    Collacott, H.
    Rentz, A.
    Krucien, N.
    Heidenreich, S.
    Ghatnekar, O.
    VALUE IN HEALTH, 2022, 25 (07) : S298 - S299
  • [8] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
    Asimakopoulos, Anastasios D.
    Kochergin, Maxim
    Colalillo, Gaia
    Fahmy, Omar
    Hassan, Fahmy
    Renninger, Markus
    Gallioli, Andrea
    Gavrilov, Pavel
    Gakis, Georgios
    BLADDER CANCER, 2023, 9 (03) : 237 - 251
  • [9] PHASE 3 STUDY OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: INITIAL RESULTS
    Dickstein, Rian
    Wu, Ning
    Cowan, Barrett
    Dunshee, Curtis
    Franks, Michael
    Wolk, Fred
    Belkoff, Laurence
    Castelucci, Sean
    Holzbeierlein, Jeffrey
    Kulkarni, Girish
    Weizer, Alon
    Lamm, Donald
    Brooks, David
    Epstein, Jonathon
    Ali, Syed
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1167 - E1167
  • [10] Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
    Kates, Max
    Matoso, Andres
    Choi, Woonyoung
    Baras, Alexander S.
    Daniels, Marcus J.
    Lombardo, Kara
    Brant, Aaron
    Mikkilineni, Nina
    McConkey, David J.
    Kamat, Ashish M.
    Svatek, Robert S.
    Porten, Sima P.
    Meeks, Joshua J.
    Lerner, Seth P.
    Dinney, Colin P.
    Black, Peter C.
    McKiernan, James M.
    Anderson, Chris
    Drake, Charles G.
    Bivalacqua, Trinity J.
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 882 - 891
12345